Clinical and neurological assessment
Alzheimer
ALZHEIMER
All participants are clinically evaluated at baseline (v0), 12 (v2), and 24 months (v4). As part of this evaluation, a neurologist or geriatrician conducted a structured anamnesis with the patient and an informant. Data collected included age, sex, educational level, medical history, cardiovascular risk factors, and treatment received. A comprehensive neurological examination was performed, and the following tests were administered: the Spanish version of the Mini-Mental State Examination testNeuropsychiatric symptoms were assessed using the Spanish version of the Neuropsychiatric Inventory Questionnaire (NPI-Q)Data from historical neurological examinations performed at Ace Alzheimer Center Barcelona’s Memory Clinic within the 3 months prior to the participant’s inclusion were used for the current study.